Fundamentals of Technology Transfer & Advanced Licensing Skills

Microbiological Challenges in the Biotechnology Industry
Includes site tour of Wyeths QC and Micro Labs (places limited)Topics addressed inclued*Brief presentation on Wyeth Biotech *Design of Biopharmaceutical Facilities *Creating Efficiencies in Cleanroom Environmental Monitoring Programs*Case Study: Recovery environmental monitoring following planned/unplanned shutdowns*Contamination Control for Biopharmaceutical Processing*Cleaning Validation in Biopharmaceutical Operations*Regulatory Aspects of Biopharmaceuticals *Mycoplasmas*Genetic Identifications in Biopharmaceuticals

Coaching: A Mandatory Skill for 21st Century Leaders
Association for Coaching presentsEXCELLENCE IN COACHINGCoaching: A Mandatory Skill for 21st Century Leaderswith Sir John WhitmoreTuesday 27 November, 2007 - DublinDATE: Tuesday 27 November 2007 15.00 - 15.30 Registration 15.30 - 18.00 Workshop 18.00 - 18.30 NetworkingSPEAKER: Sir John Whitmore VENUE: UCD Michael Smurfit School of Business Carysfort Avenue Blackrock Co. Dublin Note: there is limited on-site parking PRICE: ?32 non-members ?17.50 membersREGISTER: Register today to avoid disappointment as places are limited. event/event2i.htm If you would like to know more about this or future events please contact:Krishna De for details of Dublin Events - Dublin@associationforcoaching.comOliver Johnston for details of Belfast Events - Belfast@associationforcoaching.comAre you in a business where you are embedding coaching capabilities; or a professional coach training organisation; or perhaps a coach and interested in pursuing excellence in coaching? Then join us for a master class 'Coaching: A Mandatory Skill for 21st Century Leaders'.WHAT YOU WILL LEARNIn this content rich seminar will be led by Sir John Whitmore, Executive Chairman of Performance consultants International. The event will take the form of a Master-class and will feature a demonstration of coaching.Studies show that the real answers to achieving and sustaining high performance lies inside people. Coaching is the interactive process that unlocks this potential, enabling people to find the resources within to address the challenges they face. It helps people find from within themselves 'how to do' solutions, it does not impose 'what to do' solutions from without. Finding the 'how' is the key to the real performance, a performance that is achieved through the engagement and alignment of the whole person at work. As such the workplace has the opportunity to be a forum for personal growth, development & fulfilment. However, Sir John's proposition is that coaching is much bigger than coaching. The word 'coaching' can sometimes be limiting because people have a perception of what coaching is based on past experience. In fact, coaching models the attitudes and behaviour of the next level of psycho-spiritual evolution that is emerging in many parts of the world. The greater self-awareness and greater self-responsibility that it builds contributes not only to employee growth and development, but also to the future of our society, culture and planet. During this content rich and thought provoking Masterclass, we will explore coaching and why it is the building block for the next evolution of leadership in organisations.Sir John will be accompanied by Patrick Murphy, a member of the International Advisory Board of Performance Consultants International and Chairman of Performance Consultants Ireland.ABOUT THE SPEAKER Sir John Whitmore is Executive Chairman of Performance Consultants International. He is internationally regarded as a pre-eminent thinker in coaching, leadership and organisational development. He believes that our purpose as an organisation is to share the best leadership, social responsibility and other people skills among different countries and cultures for a sustainable future for all. Sir John has written five books on sports, leadership, and coaching, of which Coaching for Performance is the best known having sold 500,000 copies in 22 languages. You can read more about his work at IS THE EVENT FOR?1. HR practitioners and those responsible for managing and implementing coaching programmes within organisations2. Individual Coaches from all disciplines, operating privately and within organisations, whether members or non-members of the Association for Coaching3. Coaching service and training providers4. Academics working in a coaching related field5. Business owners and leaders interested in coaching.The event is eligible for CPD (continuing professional development) and certificates will be available at the event.We hope you can join us!Please pass this information on to others you think would be interested in attending.About the Association for CoachingEstablished in the UK in 2002, the Association for Coaching (AC) is an independent and non profit professional body committed to raising the standards and professionalism of Coaching. With members in 22 countries, as a key leading Professional Body, the Association for Coaching has a professional code of conduct, a vetting procedure, a course recognition and accreditation scheme, industry research, frequent CPD events and professional forums, an International Conference and other value added services. With members across the globe, the Association for Coaching is run by a team of high-energy coaching professionals committed to raising the standards and awareness of coaching, throughout Europe and beyond. DO YOU WANT TO BE KEPT INFORMED OF FUTURE EVENTS IN IRELAND?To subscribe to the AC Mailing List and receive updated information on events, research and developments within the field of Coaching, please go to: more information about the Association for Coaching in Ireland and our future events you can contact us at:acireland@associatonforcoaching.comINTERESTED IN BECOMING A MEMBER OF THE ASSOCIATION FOR COACHING?For more information about membership levels and an application form go or email

BioMed Central 11 2008 - Enabling Healthcare in the 21st Century
Wednesday 20 February 2008Connected health encompasses a diverse range of emerging technologies and services in healthcare. Connected health allows the development of patient-centred, personalized healthcare, and provides new opportunities for innovation and partnerships among researchers, practitioners, manufacturers and service providers in the Life & Health Sciences, Plastics & Polymers, and ICT sectors....

Private Equity Conference Belfast

The Whittaker Awards 2008
[image;whittakerbanner.jpg;The Whittaker Awards] The Whittaker Awards 2008 will take place on Thursday 3rd April at John Hume Building in NUI Maynooth at 7pm. The competition is organised by the NUI Maynooth Biological Society with support from the Enterprise Ireland Lifescience & Food Commercialisation group (EI Bio). This is the 29th Anniversary of the Whittaker Awards, which give undergraduate and postgraduate students an opportunity to present biological topics in an accessible, interesting and entertaining way. The Awards were named after Professor Peter Whittaker who was Professor of Biology at NUI Maynooth for 23 years.Last year's winner was Jennifer Keane. Her presentation, was titled 'Fuels Gold: The Race to Save the Planet' was one of several excellent presentations and the 2008 competition promises to be just as good.For more information email: [email;;]

9th & 10th of April 2008 - Central London - UK

Risk Based Management in Pharmaceutical Microbiology

7th Training Course on High-throughput (HT) Drug Metabolism/Disposition (DM/D),
Wll be held between May 26 and May 30, 2008 in Amsterdam, The Netherlands.The EUFEPS Committee on Industrial Relations (CIR) initiated this Course, which has become self-sustaining, a clear sign of quality and success. The course is now concentrated into five full teaching days, including lectures and demonstrations, on Monday to Friday. It will be organized in collaboration with the LACDR Section of Molecular Toxicology, and the Department of Pharmacochemistry, Vrije Universiteit (Free University), Amsterdam.Specific and general goals of the Course include:To stimulate interdisciplinary learning of HT drug metabolism/disposition. To learn to critically evaluate the basic concepts of HT technologies in drug metabolism/disposition. To learn the possibilities but also the limitations of HT-drug metabolism/disposition technologies. To train attendees in the most relevant HT drug metabolism/disposition technologies. To stimulate research in and applications of HT drug metabolism/disposition. To prepare new industrial and academic recruits better to meet the challenges of HT technologies in drug metabolism/disposition. To increase the general standard of the use of HT technologies in drug metabolism/disposition. To attract long term funding (e.g. from the EC) for a permanent training centre in HT drug metabolism/disposition. To attract investments in HT drug metabolism/disposition technologies in academia, thereby improving the facilities for (undergraduate/graduate/PhD) training of future employees in industry and academia. Post-doctoral/advanced PhD (or equivalent) level attendees from industry and academia, as well as those working in pharmaceutical, bio-technological, bio-analytical, agro/fine chemical and (bio)informatics areas, should not miss this opportunity and should rush to register. The number of attendees is limited to a maximum of 25.Detailed information about this course is available on www.eufeps.orgDaan J.A. Crommelin, Professor EUFEPS President

Reporting Failure Investigations and Process Deviations
Dublin, Ireland

Adverse Drug Events - Reporting & Regulatory Requirements
Berlin, Germany

Root Cause Analysis for CAPA
Dublin, Ireland

Effective Quality Assurance Auditing for FDA Regulated Industries
Dublin, Ireland

CMC Regulatory Compliance for Biopharmaceuticals and Biologics

Writing Effective Standard Operating Procedures and Other Process Documents

QA/QC Strategy for Biopharmaceuticals and Biologics

cGMP Quality Principles for Pharmaceuticals, Biopharmaceuticals, Biologics and Medical Devices

Pharmaceutical and Biopharmaceutical Quality Control Laboratories - A Regulatory Compliance Primer

Introduction to Effective Medical Writing

Medical Devices - EU Directives, Guidance, CE Marking and ISO Standard Certifications

FDA Inspections of Clinical Data Systems

The EU Clinical Trial Directive

European Filing & Registration Procedures

Practical Methods for Project Management

Root Cause Analysis for CAPA

Clinical Trial Design for Medical Devices

Overview of FDA Regulatory Compliance for Medical Devices

The Drug Development Process - From Discovery to Commercialization

The EU Clinical Trial Directive

European Filing & Registration Procedures

Medical Devices - EU Directives, Guidance, CE Marking and ISO Standard Certifications

Auditing and Qualifying Suppliers and Vendors

Effective Document Management for Pharmaceutical, Biotech, & Medical Device Industries

Drug Master Files (DMFs) - Understanding and Meeting Your Regulatory and Processing Responsibilities

Stability Programs for Product Shelf Life - From Development to Approval

The CTD/eCTD: Building the Marketing Application throughout Clinical Development

Pharmaceutical and Biopharmaceutical Quality Control Laboratories - A Regulatory Compliance Primer

Analytical Method Validation for Biologics, Biopharmaceuticals and Other Therapeutic Products

Effective Document Management for the Pharmaceutical, Biotech & Medical Device

Innovation in Separations Science
With the huge success of UPLC and MS in the Irish market this year, Waters is delighted to announce Innovation in Separations Science (ISS) 2011, a unique forum where Irish scientists will present their innovative applications of our technologies.The program consists of lectures in both basic and advanced topics from guest speakers and Waters specialists. Dependent on your interests, you can choose which of the 4 parallel sessions you wish to join. This will be a wonderful opportunity to meet with colleagues and discuss the challenges faced in enhancing productivity while keeping costs down.There will be a gala dinner on the night of the 5th of April with our celebrity guest speaker Michael O'Muircheartaigh.

QA/QC Strategy for Biologics and Biopharmaceuticals

cGMP Quality Principles for Pharmaceuticals, Biopharmaceuticals, Biologics and Medical Devices

Integrated Tablet Formulation Development
This unique 2 day course introduces and integrates the key elements of tablet development based on the principles of Quality by Design (QbD) set out in ICH Q9. It will include experimental, hands-on experience of formulation development and will cover: * The product development lifecycle* Preformulation studies * Formulation development[MEMBERS_IMAGE_RIGHT;a322252.png;Integrated Tablet Formulation Development] Proper integration of all of these elements is essential to achieve 'Quality by Design' because data from each phase is used to control the next step in the development process. By achieving proper integration based on sound scientific principles, many development and production problems can be avoided. The course includes case studies of tablet development at the preformulation and formulation development phases as well a detailed step by step analysis of all elements of the tablet manufacturing process. Hands on, practical studies will underpin the scientific learning in this participative course.

Introduction to Effective Medical Writing

Development and Validation of Bioanalytical Assays for Biologics: Quantification (PK) And Immunogenicity Assays

How to Audit API Manufacturers
This one day seminar is aimed at QA staff in drug products manufacturers and especially their QPs who have specific responsibilities under directive 2004/27/EC.QPs are required to declare that the active materials used in each of their products have been manufactured to GMP as interpreted by the EU.Participants will learn about the[MEMBERS_IMAGE_RIGHT;a320966.png;How to Audit API Manufacturers] legislators' perspectives and the key differences between APIs and products, which lead to different audit techniques and thought processes when auditing API manufacturers. The seminar includes: the background to current GMPs for APIs FDA and EU interpretation of GMPs for APIs specific opportunities from the guidelines that API manufacturers may exploit specifics of what to look for when auditing an API site. Who should attend**Supplier auditors for drug products manufacturers **QPs in manufacture of drug products **QA managers who support the QP / declaration **QC managers of drug products manufacturers **Production managers of drug products manufacturers

Tablet Formulation Development, Validation and the application of QbD
This interactive workshop provides up-to-date, relevant and detailed information on the impact of Quality by Design (QbD) on the Development and Validation of tablet manufacturing processes. It will also study the identification and evaluation of Critical Product Attributes and Critical Process Parameters for tablets, and their implications for[MEMBERS_IMAGE_RIGHT;a322253.png;Tablet Formulation Development, Validation and the application of QbD] process control. We develop new concepts including the use of risk and process matrices for risk management. The latest ICH and FDA guidance on Quality by Design and Process Development, published in 2009, will be comprehensively reviewed.By the end of the course, you will: * Understand the relationship between the principles of QbD and tablet development and process validation in generic and new product development * Understand the relationship between material properties, formulation development and process development * Understand the processes commonly used to manufacture tablets and the factors which affect them Recognise how to identify critical processing parameters, and how to incorporate into a process validation program * Understand the principles of PAT, how and where it can be most effectively deployed * Know the latest FDA thinking on Process Development including the three key steps of validation

GMP Auditor Training
This 2 day course is aimed at Quality Assurance auditors and production management for Level 2 internal audits and supplier auditing.To be a business benefit rather than a drain on resources, your auditing programmes must be integral to continuous improvement. The key to effective internal auditing and auditing of suppliers is the training of[MEMBERS_IMAGE_RIGHT;a320964.png;GMP Auditor Training] both auditors and auditees in the purpose and relevant techniques of the audit and how these techniques can be channelled to achieve business and compliance improvements.Participants will learn about the key techniques and thought processes which may be used by auditors to maximize the benefits of each type of audit. These include planning and preparation, the audit team, structuring the audit, close out, CAPAs and follow up.Who should attend? *** QA auditors and trainees Production managers who receive internal QA and corporate GMP audits *** Engineering managers who receive internal QA and corporate GMP audits *** Production supervisors who lead Self Inspection audits *** Auditors of suppliers and contractors

Writing Effective Standard Operating Procedures and Other Process Documents

Supply Chain Management in Pharma/Biotech
This 2-day workshop aims to provide participants with a complete overview of professional supply chain management processes used across all sectors and then spotlight the issues and opportunities that exist specifically within pharmaceuticals.The format of the workshop will be interactive, using case study exercises. Participants will be[MEMBERS_IMAGE_RIGHT;a322254.png;Supply Chain Management in Pharma/Biotech] encouraged to bring along any burning questions that exist within their organisations for discussion (whilst maintaining confidentiality).Just some of the benefits to be derived from this workshop include:* Vastly increased value delivery from CRO's and CMO's and other service providers.* Focus on the actions that can transform supply-chain performance.* Reduced risk of delays and failure in getting drug to site or channel.* Stronger and tighter third party relationships and agreements.* Enhanced control of inventory investment, availability and traceability.* Ability to perform risk assessments and mitigation plans for the supply network.* Appreciation of how to build shared understanding of CMC activities within project management teams.* Increased confidence in driving continuous improvement through your supply chains.Who should attend? * Staff wishing to understand how effective supply chain management can contribute significant benefits to an organisation. This would include Project Managers, Clinical and Non-Clinical project team members, Contract Managers, Quality and Compliance, Finance, Regulatory Affairs, Marketing and Business Development.

Technology Transfer
This 2-day interactive workshop is intended to provide an overview of the challenges that must be overcome in transferring technology and to highlight some proven techniques for overcoming those challenges.Some of the benefits to be derived from this workshop include: **An appreciation of where TT fits in the life cycle of a pharmaceutical[MEMBERS_IMAGE_RIGHT;a320968.png;Technology Transfer] product **An appreciation of the importance of planning and product transfer **An overview of the potential complexity of technology and product transfer **An outline of proven best practice in technology transfer **An opportunity to discuss current issues and challenges in technology transfer with peers and with an expert faculty -Day 1-Why Transfer Technology? Pharmaceutical Product Life Cycle o Development o Innovative o Mature o Generic Product Transfers and Technology Transfers o IP o Technology o TechniquesRegulatory Considerations Registration Procedures o Europe o Non-European Variation Procedures o Types of Variations o Advantages and Disadvantages -Day 2-Technical Challenges Manufacturing processes Validation Stability Packaging processesLogistical Challenges Label Changes o Text o Physical Timing o Project Plan o Phase in/outHuman Challenges Push versus Pull Team membership and team roles Cross-Cultural Issues Progress Reporting and breaking bad news

Practical Methods for Project Management

Process Validation for Medical Devices

Stability Testing in Pharmaceutical Development and Manufacture
The purpose of this course is to give a comprehensive, integrated overview of pharmaceutical stability testing. It will include, A comprehensive review of ICH guidance, Pitfalls in stability testing, Outsourcing-costs and benefits, New approaches to stability testing including ASAP, Stability Testing and QbD and Workshops for attendees to[MEMBERS_IMAGE_RIGHT;a322257.png;Stability Testing in Pharmaceutical Development and Manufacture] present and discuss their own stability testing issues with the group. Who should attend:The course is designed for people working in: * Analytical Development * Analytical Chemistry * Stability Testing * Formulation Development * Regulatory Affairs * Pharmaceutical & Biopharmaceutical Production * Product Development * Technical Operations

FDA Inspections - What Regulators Expect and How to Prepare

Comprehensive Overview of FDA Regulatory Compliance for Drugs and Biologics

How to Implement Risk Management Principles and Activities within a Quality Management System

Clinical Document Management - A Trial-by-Trial Approach to Compliance

Project Management for Phase 1 & 2 Clinical Trials

Project Management for the Phase 3 and LCM (Life Cycle Management)

FDA Inspections of Clinical Data Systems

Pharmacokinetics in Drug Development - an integrated approach
The object of this course is to provide participants with an overview of the principles of Pharmacokinetics and Pharmacokinetic/Pharmacodynamic modelling and how together with regulatory guidances they can be used to effectively deliver drug development programmes. Participants will gain an understanding of the common PK terms and their[MEMBERS_IMAGE_RIGHT;a322258.png;Pharmacokinetics in Drug Development - an integrated approach] importance, an understanding of how PK data influences the clinical development programme, an understanding of the factors that contribute to variability in PK, the role of PKPD modelling in drug development , an appreciation of how regulatory guidances influence PK and an increased confidence to discuss PK issues within their drug projects.

Centralized Monitoring, Alarming and Reporting System Workshop
Join us for a free Seminar and learn more about the Labwatch Centralized Monitoring, Alarming and Reporting System. Venue: GE Sensing - Shannon, Ireland

An introduction to LC-MS for Pharma Industry
This one-day course provides an introduction to technology and (potential) application areas of combined liquid chromatography-mass spectrometry (LC-MS) in small-molecule pharmaceutical industry. The morning sessions provide a clear technology overview, introducing analyte ionization techniques, different types of mass analysers, and important[MEMBERS_IMAGE_RIGHT;a322260.png;An introduction to LC-MS for Pharma Industry] data acquisition strategies.The two afternoon sessions focus on applications in quantitative and qualitative analysis, respectively.

Quantitative Bioanalysis using LC-MS
This advanced application-oriented two-day course in LC-MS pays attention to the important aspects of quantitative bioanalysis by LC-MS, except for statistical aspects in data-processing. Starting from providing knowledge on important processes in analyte ionization by electrospray or APCI, the course provides a profound understanding of the[MEMBERS_IMAGE_RIGHT;a322261.png;Quantitative Bioanalysis using LC-MS ] important topics of quantitative bioanalysis using LC-MS. Quality control in instrument performance, method development, and systematic troubleshooting are key issues throughout the course. The theoretical parts of the course are illustrated with a number of case studies. Experience with the LC-MS instrumentation is recommended prior to attending this course The aim is to provide the participants with the general principles, background knowledge, and how to use this knowledge in practice.

Writing effective SOPs in a GMP environment
This course provides helpful information by presenting topics associated with the writing, formatting, execution, management and global harmonization of SOP's. It also discusses good documentation practices required by companies to ensure GMP compliance and relates the role which SOP's play in achieving the required level of compliance and[MEMBERS_IMAGE_RIGHT;a322255.png;Writing effective SOPs in a GMP environment] quality. The course material is presented by means of slides, handouts and participation of the attendees through discussion and individual/group exercises. Note: Participants may bring an SOP related to their work for the workshop exercise on day two.The workshop emphasises practical issues such as:* The benefits of SOP's* The logical approach to defining and writing the procedure section of the SOP* Writing SOP's as part of a team* Critiquing an example of a badly written SOPThe course provides ample opportunities for group discussions and hands on exercises. It enables participants to gain the skills and knowledge necessary to meet the expectations of regulatory agencies.

OOS investigations in a GMP environment
This course is designed to provide essential training for conducting Out of Specification (OOS) investigations in a GMP environment. A background discussion of the associated GMP documentation required to support the OOS investigation is included but the majority of time is spent detailing the who, what, when, how and why of the investigation,[MEMBERS_IMAGE_RIGHT;a322256.png;OOS investigations in a GMP environment] determining the extent of the investigation during Phase I and Phase II, documenting findings determining root causes and assigning corrective and preventative actions. This course is presented in a dynamic environment created by a power point presentation, interactive exercises, case studies and group discussion. Participants are welcome to bring their own examples for group discussion sessions.The workshop emphasizes practical issues such as:* The importance of good quality support systems* FDA audit observations and how they could have been avoided* Case studies* A detailed guide to conducting Phase 1 and Phase II of the investigation* Reporting and evaluating passing and failing resultsThe course provides ample opportunities for group discussions, case studies and exercises. It enables participants to gain the skills and knowledge necessary to meet current regulatory expectations. The course material is based on the FDA guideline 'Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production', October 2006

HPLC Analytical Method Development and Validation
Analytical methods must be validated to provide reliable data for regulatory submissions. These methods are essential for a number of purposes, including testing for QC release, testing of stability samples, testing of reference materials and to provide data to support specifications. This course provides a comprehensive coverage of the method[MEMBERS_IMAGE_RIGHT;a320967.png;HPLC Analytical Method Development and Validation] development and validation requirements that are essential to progress a pharmaceutical compound, at each stage of product development. Upon completion of this course, delegates will have learned what is necessary to develop and validate methods for drug substance and drug product to comply with international regulatory guidelines. The course is designed for: Scientists working with HPLC who need to further their understanding of the technique in order to develop better methods faster. Scientists who have to validate methods HPLC methods in accordance with current internationally-accepted guidance. HPLC technicians working in R&D laboratories, quality control laboratories and stability testing laboratories. Managers with a responsibility for generating regulatory submissions.

Development and Manufacture of Effervescent Tablets
About this course:Effervescent products present particular problems in manufacture, which result from their special requirements and particular utility. In this one day workshop led by two leading experts, the issues surrounding the development and manufacture of effervescent products are explored in depth including practical[MEMBERS_IMAGE_RIGHT;a322293.png;Development and Manufacture of Effervescent Tablets] sessions.Background:* What are the advantages and disadvantages of effervescent tablets?* What are their particular requirements?* Why do they present problems?The course is designed for people working in formulation, process development or manufacturing with responsibility for the development, validation and manufacture of effervescent products. The content will complement that of the Tablet Formulation and Tablet Process Development courses which immediately precede it.COURSE PROGRAMMETry it!! The workshop...Using a laboratory tablet machine and some simple equipment, we experiment with effervescence and develop some simple products.Theory* Effervescence systems. What are they and how to they achieve their objectives* Uniformity - achieving and assessing uniformity in effervescent systems.* Taste and taste masking* ODTs* Specific problems with effervescent products-mixing, lubrication, compression.Practice. Effervescent products in Production.* Engineering requirements for effervescent products* Process Validation-challenges and pitfalls* Scale up and Technology Transfer-mixing issues* Routine manufacture

Pharmaceutical Packaging - an introductory course
Pharmaceutical Packaging is a very specialised area with its own unique issues and problems. This one day course will provide delegates with a good basic grounding and appreciation of what is required for the packaging of pharmaceutical and healthcare products. Whether you know nothing, have a basic understanding or are familiar with the area,[MEMBERS_IMAGE_RIGHT;a320969.png;Pharmaceutical Packaging - an introductory course] this course will provide you with the useful knowledge and insights from experts who have each worked in the industry for over 25 years.What it covers?** Packaging component and material selection** Key properties of various packaging materials/systems** Pack testing and evaluation** Packaging component specifications** Printing processes and controls** Artwork generation and control** Regulatory requirements eg MA packaging requirements, Braille, 2D Data Matrix barcodes, Child resistance, Tamper Evidence, Readability and others** Transit packaging** Trade/Supply Chain requirementsWho should attend** Account Managers** Artwork Producers** Auditors** Business Developers** Clinical Trial Suppliers** Logistics Personnel** Packaging Design/Labelling Personnel** Packaging Technologists ** Project Managers** Purchasers** Quality Assurance and Control Personnel** Regulatory Personnel** Suppliers to the industry** Technical Writers

Introduction to Photostability
The purpose of this course is to give an overview of photostability,and where it fits in the stability testing programme and the importance of photostability. The course is highly interactive and held in a relaxed environment.It will cover:* Why do we do photostability tests?* Concepts and background in photostability* Identifying drug[MEMBERS_IMAGE_RIGHT;a322259.png;Introduction to Photostability] substances most likely to absorb light and display signs of poor photostability* Understanding photostability terminology* Where does phototstability fit in the overall stability testing program? * Why does photostability matter? (exercise)It will benefit those working in:* Analytical Development * Analytical Chemistry* Stability Testing * Technical Operations* Research and Development Chemistry* QA/QC* Formulation Development * Pharmaceutical & Biopharmaceutical Manufacturing/Production * Product Development* Regulatory Affairs * GLP/GMP Compliance

SBE's 4th International Conference on Bioengineering and Nanotechnology (ICBN) 22-24 July 2008, UCD, Dublin, Ireland

Innovation and Technologies Showcase


Trinity College Dublin’s Technology Transfer Office will be hosting  the annual Innovation and Technologies Showcase in the O’Reilly Institute on Thursday 4th October 2012,  from 4-8pm

With Trinity’s record of 27 spin-out companies in the last 5 years, this showcase is a must-see for business partners, investors and entrepreneurs alike. This year’s 30+ projects offer real commercial opportunities, demonstrating the benefits of research for the economy and the community.  


please see link to further details and registration


Big Ideas Technology Showcase


Sometimes the big ideas in med-tech innovation are about getting a better edge. Perhaps a hip replacement with tiny, directional claws on its surface that gives the implant a better grip in the recipient's thigh bone. Or 'self-cleaning' hospital uniforms, where nanoparticles on the textile become activated by light and can kill potentially dangerous bacteria lurking on the fabric.  

These are two of several innovative ideas that will be presented this week at Enterprise Ireland's Big Ideas Technology Showcase inDublin.

Economic relevance

Seán Sherlock, Ireland's Minister for Research and Innovation, will be at Big Ideas to present commercialisation awards.

He tells the event highlights the economic relevance of publicly funded research that's managed through agencies, such as Enterprise Ireland and Science Foundation Ireland: "It's a great showcase for where that spend is going."

Industry engagement on the day is vital to its success, he adds.

"This will lead to new spin-out companies, to increased licensing of technologies and to growing existing Irish companies," says Sherlock. "It's also an ideal opportunity for people to establish contacts in academia and industry."

Enterprise Ireland's Big Ideas Technology Showcase takes place at the Aviva Stadium inDublin on 28 November.